The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells
Article in Frontiers in Immunology (August 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (August 2024)
Article in Antibodies (July 2024)
Article in Cardiovascular Research (April 2024)